Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-Biotin PET/CT in Cancer
NCT06740240Phase 1Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Mar 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 68Ga-FAPI-Biotin in solid tumor (2 arms), sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Diagnostic value at 3 months. Started Mar 2024; status: recruiting.
02
Drugs
68Ga-FAPI-Biotin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06740240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06740240.